Reduced Risk of Cardiovascular Diseases after Bariatric Surgery Based on the New PREVENT Equations

Lei Wang1, Xinmeng Zhang2, You Chen3

  • 1Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Insights

Bariatric surgery significantly improves cardiovascular-kidney-metabolic health and reduces heart failure risk by over 50% within two years. These improvements highlight surgery

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Health
  • Surgical Outcomes

Background:

  • Bariatric surgery is increasingly performed, necessitating evaluation of its long-term impact on cardiovascular-kidney-metabolic (CKM) health.
  • Cardiovascular disease (CVD) remains a significant concern, and its risk stratification is crucial, especially post-bariatric procedures.

Purpose of the Study:

  • To assess the impact of bariatric surgery on CKM health and estimate changes in CVD risk, including heart failure (HF).
  • To utilize the novel Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations for risk assessment in this population.

Main Methods:

  • Retrospective analysis of 7804 patients undergoing bariatric surgery from 1999-2022.
  • Extracted pre- and post-surgery CVD risk factors (systolic blood pressure, cholesterol, eGFR, etc.).
  • Applied social deprivation index-enhanced PREVENT equations to estimate 10- and 30-year risks for total CVD, ASCVD, CHD, stroke, and HF.

Main Results:

  • Significant improvements in CKM health observed post-surgery, including lower blood pressure, non-HDL cholesterol, and diabetes prevalence, alongside higher HDL and eGFR.
  • 10-year total CVD risk decreased by 25.9% at 1 year and 16.8% at 2 years post-surgery.
  • Heart failure risk showed the most substantial reduction (55.7% at 1 year, 44.8% at 2 years), with variations noted across patient subgroups.

Conclusions:

  • Bariatric surgery markedly enhances CKM health and substantially reduces estimated CVD risk, particularly for HF.
  • The magnitude of HF risk reduction varies based on patient demographics, weight loss achievement, and pre-existing conditions, suggesting areas for further investigation.
Abstract